Bayer Climate Program

Vector control in malaria

Climate change is causing the mean global temperature to rise, and this in turn is encouraging insects to reproduce and spread into regions which they were not previously able to colonize. In addition to the problem of larger numbers of potential disease vectors, the task of controlling vector-borne infectious diseases is made more difficult by the growing resistance of vectors to established insecticides.

Eine Stechmücke im Sturzflug: Da kann Gefahr drohen. Von schmerzhaften und juckenden Stichen abgesehen, sind Mücken in den Tropen auch Überträger lebensbedrohender Krankheiten.

A mosquito coming in to land. A potentially dangerous event. In addition to delivering painful, itchy bites, mosquitoes in the tropics are vectors of life-threatening diseases.

The key to stopping the progress of and eliminating such diseases is the control of transmission of infectious tropical diseases such as malaria by containing or reducing vectors. This can only be done with suitable insecticides, formulations (e.g. ‘space sprays’) and forms of application (e.g. in mosquito nets).

With the aim of mastering the associated challenges and accelerating the development of resistance-free products suitable for controlling malaria, Bayer has entered a public private partnership with the Innovative Vector Control Consortium (IVCC), an organization based in Liverpool, United Kingdom, which is funded by the Bill and Melinda Gates Foundation.

The collaboration applies to three areas:

1. Development of a long-acting insecticide formulation for in-house spray application

2. Development of new, resistance-busting insecticides based on a particularly efficient class of
chemical compounds

3. Development of a new insecticide research platform for the public health system.

Bayer is opening its substance library – one of the most extensive in the world – for the first time as part of this collaboration.

Last updated: February 11, 2015 Copyright © Bayer AG